Reference
Huesgen E, et al. Severe dyslipidaemia after the addition of raltegravir to a lopinavir/ritonavir-containing regimen. Antiviral Therapy 17: 1385-1388, No. 7, 22 Jun 2012. Available from: URL: http://dx.doi.org/10.3851/IMP2182 - USA
Rights and permissions
About this article
Cite this article
Lopinavir/ritonavir/raltegravir interaction. Reactions Weekly 1436, 24 (2013). https://doi.org/10.1007/s40278-013-0943-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-0943-6